Information Sheet

This information sheet discusses the burden and challenges of TB in women. It states that TB is the second leading cause of death from a single infectious agent worldwide.

This information sheet discusses the challenges to drug resistant gonorrhea, why we should care about it, which regions experience the most cases, and prevention efforts to prevent an epidemic.

This information sheet provides general information about TB is, how someone can be exposed and how to test for TB. It explains that TB is spread through the air after someone with TB disease sneezes, coughs, speaks, laughs, or sings. Latent TB infection is when TB germs live in the body without making the individual sick. If the germs become active, they cause TB disease. The two tests used to help detect TB are the skin test and a special TB blood test. Other tests include chest X-ray and sputum test.

This information sheet discusses parent engagement in schools, which it defines as parents and school staff working together to support and improve the learning, development, and health of children and adolescents. It also discusses ways in way engagement can occur, what research shows, and types of engagement.

This information sheet is to help guide fathers to influence their teenagers sexual risk behaviors in positive ways. It encourages fathers to monitor and supervise their teen, be involved in their lives, communicate well, and share their values. It also provides a list of resources for additional information and assistance.

This information sheet discusses the Xpert MTB/RIF Assay for diagnosing TB. It explains that the new test is a nucleic acid amplification test that diagnoses TB in less than 2 hours and can also determine resistance to rifampin, one of the drugs used to treat TB. The information sheet describes how the Xpert MTB/RIF assay works, its advantages, how the results should be interpreted, what it means if RIF resistance is detected, not detected, or is indeterminate. Addresses for additional information are provided.

This information sheet illustrates CDC’s new recommendations for laboratories to capitalize on the latest available technologies in HIV testing to help diagnose infections as much as 3-4 weeks sooner than the previous testing approach. Early diagnosis is critical since many new infections are transmitted by people in the earliest (“acute”) stage of infection.

This information sheet discusses the importance of adhering to an HIV treatment regimen. It lists steps that should be taken before beginning treatment to help the patient maintain adherence and suggestions to help the patient after beginning treatment. It advises contacting the doctor if adhering to treatment is a problem as the doctor may have other treatment options.

This information sheet discusses the liver biopsy. It explains a liver biopsy; the risks involved; how a liver biopsy can help, particularly for people with Hepatitis C; how it is done; and what happens after the liver biopsy is done. It also discusses when one should not have a liver biopsy. The information sheet specially emphasizes that a person who takes medicine for hepatitis C might need to have more than one liver biopsy.